Product Information
PALIPERIDONE ER 9 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.3294 per EA under NDC 68180052606. Its NADAC has been published 146 times since May 10, 2023.
FDA first approved this application on Jun 29, 2022.
The High Outlier badge above means this manufacturer's average price in the Paliperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
9 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180052606
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA208643FDA Approved
6/29/2022
On Market Since
10/19/2022
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 9 MG TABLET has been published 146 times since May 10, 2023, and over the history we have for it it has declined 50.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3294 per EA |
|---|---|
| All-time high | $3.1485 (Jul 12, 2023) |
| All-time low | $1.3294 (Feb 18, 2026) |
| 52-week high | $1.5808 |
| 52-week low | $1.3294 |
| Median price | $1.8926 |
| Average price | $1.9634 |
| Largest weekly change | +65.2% (Aug 21, 2024) |
| Weeks tracked | 146 |
| Tracking since | May 10, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-15.9%
3Y
-53.1%
5Y
N/A
All
-50.9%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 9 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $1.3294 per EA (NDC 68180052606), effective Feb 18, 2026.
How has the price of PALIPERIDONE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 9 MG TABLET has declined 50.9%. It has been tracked across 146 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 9 MG TABLET?
Since May 10, 2023, the NADAC for PALIPERIDONE ER 9 MG TABLET has ranged from a low of $1.3294 (Feb 18, 2026) to a high of $3.1485 (Jul 12, 2023), with a median of $1.8926 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 9 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PALIPERIDONE ER 9 MG TABLET, is $1.0186 per EA — about 23% below PALIPERIDONE ER 9 MG TABLET.
Who manufactures PALIPERIDONE ER 9 MG TABLET?
PALIPERIDONE ER 9 MG TABLET (NDC 68180052606) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.